Prevention of hepatitis B and C in the EU/EEA and the UK
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
Hepatitis B - Annual Epidemiological Report for 2018
For 2018, 30 EU/EEA Member States reported 24 588 cases of hepatitis B virus (HBV) infection. When the five countries that only reported acute cases are excluded, the number of cases is 24 034, which corresponds to a crude rate of 6.0 cases per 100 000 population.
Hepatitis C - Annual Epidemiological Report for 2018
In 2018, 37 527 cases of hepatitis C were reported in 29 EU/EEA Member States. The number is 37 427 when countries that only reported acute cases are excluded, which corresponds to a crude rate of 8.8 cases per 100 000 population.
Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019
This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries.
Toolkit to support the generation of robust estimates of hepatitis C prevalence
European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices. The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.
Reorienting health systems to care for people with HIV beyond viral suppression
Safreed-Harmon, K., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., del Amo, J., Kall, M., Noori, T., Porter, K., Lazarus, J.V.
HIV among women in the WHO European Region - epidemiological trends and predictors of late diagnosis, 2009-2018
Mårdh, O., Quinten, C., Kuchukhidze, G., Seguy, N., Dara, M., Amato-Gauci, A.J., Pharris, A., On Behalf Of The Ecdc/Who Hiv Surveillance Network
HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
Desai, S., Tavoschi, L., Sullivan, A.K., Combs, L., Raben, D., Delpech, V., Jakobsen, S.F., Amato-Gauci, A.J., Croxford, S.
HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
Croxford, S., Tavoschi, L., Sullivan, A.K., Combs, L., Raben, D., Delpech, V., Jakobsen, S.F., Amato-Gauci, A.J., Desai, S.
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.